We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Nov 2019
  • Code : CMI101
  • Pages : 166
  • Formats :
      Excel/PDF
  • Industry : Biotechnology
Ingographics Image

Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson’s disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.

Market Dynamics

The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.

Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter’s voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.

Key features of the study:

  • This report provides in-depth analysis of the global vocal biomarkers market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019 – 2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global vocal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Coporation, and Cogito Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
  • The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market

Detailed Segmentation:

  • Global Vocal Biomarkers Market, By Therapeutic Application:
    • Psychological Disorders
      • Depression and Anxiety
      • Parkinson’s Disease
      • Cognitive Impairment
      • Other Mental Illnesses
    • Respiratory Disorders
    • Cardiovascular Disorders
  • Global Vocal Biomarkers Market, By End User:
    • Hospitals
    • Health Insurers
    • Academic & Research Institutions
    • Government Organizations
  • Global Vocal Biomarkers Market, By Region:
    • North America
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Beyond Verbal, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sonde Health
    • Sharecare, Inc.
    • IBM Coporation
    • Cogito Corporation

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Therapeutic Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Epidemiology/Prevalence/Incidence
    • Mergers and Acquisitions Scenario
    • New Product Approvals/Launch
  4. Global Vocal Biomarkers Market, By Therapeutic Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Psychological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Depression and Anxiety
        • Parkinson’s Disease
        • Cognitive Impairment
        • Other Mental Illnesses
    • Respiratory Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cardiovascular Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Vocal Biomarkers Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Health Insurers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic & Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Government Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Vocal Biomarkers Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Beyond Verbal, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sonde Health Inc.
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sharecare, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • IBM Coporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cogito Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 27 market data tables and 22 figures on "Vocal Biomarkers Market - Global forecast to 2027”.

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.